Trump blames US case surge on protesters; WHO warns pandemic is “one big wave”, not seasonal; Air travel not expected to recover until 2024. Follow the latest updates
- Covid-19 still accelerating, warns WHO, as restrictions return in Europe
- Twitter limits Donald Trump Jr’s account for posting misinformation
- Clapped out of ICU, dead days later: the secondary impact of Covid-19
- Outbreak in Xinjiang prompts fears of spread inside Uighur camps
- See all our coronavirus coverage
1.28am BST
Charlotte Graham-McLay reports for the Guardian:
New Zealand’s national airline, Air New Zealand, has frozen all new ticket bookings to Australia until 28 August.
In a statement, the airline said the hold was due to Australian government restrictions on the number of passengers arriving in the country. The limits were introduced to alleviate pressure on quarantine facilities, and mean airports like Brisbane can only accept 70 passengers per day, while services bringing Australians back to Sydney are limited to as few as 30 travellers per flight.
International passenger arrivals into Melbourne are not permitted until 8 August.
Cam Wallace, a spokesman for the airline, said that while the Australian government restrictions are in place until 8 August, the airline is placing a longer freeze on future bookings to “help prevent disruptions” to travelers’ journeys should the restrictions be extended.
Air New Zealand’s current trans-Tasman flights are from Auckland to Sydney, Brisbane and Melbourne, with flights to Melbourne only carrying cargo.
1.25am BST
Moderna Inc is planning to price its coronavirus vaccine at US$50 to $60 per course higher than other vaccine makers have agreed to charge governments, the Financial Times reported on Tuesday.
The price would apply to the United States and other high-income countries, according to the report.
Moderna was not immediately available for comment.
You can see how close we are to a coronavirus vaccine with the Guardian’s tracker below:
Related: Coronavirus vaccine tracker: how close are we to a vaccine?
Continue reading…Trump blames US case surge on protesters; WHO warns pandemic is “one big wave”, not seasonal; Air travel not expected to recover until 2024. Follow the latest updatesCovid-19 still accelerating, warns WHO, as restrictions return in EuropeTwitter limits Donald Trump Jr’s account for posting misinformationClapped out of ICU, dead days later: the secondary impact of Covid-19Outbreak in Xinjiang prompts fears of spread inside Uighur campsSee all our coronavirus coverage 1.28am BSTCharlotte Graham-McLay reports for the Guardian:New Zealand’s national airline, Air New Zealand, has frozen all new ticket bookings to Australia until 28 August. In a statement, the airline said the hold was due to Australian government restrictions on the number of passengers arriving in the country. The limits were introduced to alleviate pressure on quarantine facilities, and mean airports like Brisbane can only accept 70 passengers per day, while services bringing Australians back to Sydney are limited to as few as 30 travellers per flight.International passenger arrivals into Melbourne are not permitted until 8 August.Cam Wallace, a spokesman for the airline, said that while the Australian government restrictions are in place until 8 August, the airline is placing a longer freeze on future bookings to “help prevent disruptions” to travelers’ journeys should the restrictions be extended.Air New Zealand’s current trans-Tasman flights are from Auckland to Sydney, Brisbane and Melbourne, with flights to Melbourne only carrying cargo. 1.25am BSTModerna Inc is planning to price its coronavirus vaccine at US$50 to $60 per course higher than other vaccine makers have agreed to charge governments, the Financial Times reported on Tuesday. The price would apply to the United States and other high-income countries, according to the report. Moderna was not immediately available for comment.You can see how close we are to a coronavirus vaccine with the Guardian’s tracker below: Related: Coronavirus vaccine tracker: how close are we to a vaccine? Continue reading…